Cancer Quality Initative Seminar

Established in 2007, GHC's Cancer Quality Initiative (CQI) seminar series is designed for key hospitals (mainly accredited cancer institutes) dedicated to improving the quality of care for cancer patients.

With 200 participating hospitals at present, GHC carries out a benchmarking exercise for clinical pathways and treatment outcomes based on data from all participating hospitals. The non-anonymized data is shared amongst participating hospitals, in order for hospitals to openly compare, discuss and share their best practices with one another - leading hospitals to the ultimate goal of a uniformed, quality approach towards cancer treatment across Japan.

Prefectural Hospital Consortiums

GHC co-organizes consortiums for prefectural hospitals in collaboration with the relevant prefectural bodies. Prefectural hospitals gather to compare their performance through a non-anonymized benchmarking exercise at these consortiums, and exchange ideas and plans for improved hospital administration practices.　　　　　　
　
　
　

Stanford University

GHC engages in collaborative research with Stanford University (where GHC Chairman, Dr. Aki Yoshikawa was the Associate Director of the Comparative Health Care Policy Research Project, Asia / Pacific Research Center), working particularly closely with Professor Jay Bhattacharya and his team.

One of the research projects was "A Comparison of the Geographic Variation in Surgical Outcomes and Cost Between the US and Japan", where the larger extent of cost variability in the US and the presence of higher geographic variation in post-operative outcomes in Japan were brought to light.
　

Mayo Clinic

GHC also carries out collaborative research with the renowned Mayo Clinic.

One of our joint research projects involved a cross-sectional study of patient outcomes and costs in total joint replacement procedures, where it was surfaced that facilities with a lower procedural volume have a tendency towards a higher rate of post-operative complications, and there is significant variability in LOS and per case expenditures for total joint replacement in Japan.